US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals Incorporated | $451.63 | -1.6% | $114.88B | 29.5 | 530.1% | — | Healthcare | 0.7% | 10.4% | ||
| 2 | Regeneron Pharmaceuticals, Inc. | $609.94 | 0.3% | $63.37B | 14.7 | 4.5% | 0.6% | Healthcare | 18.8% | 5.9% | ||
| 3 | argenx SE | $877.72 | -1.6% | $54.32B | 44.7 | 279.7% | — | Healthcare | 63.2% | 174% | ||
| 4 | Alnylam Pharmaceuticals, Inc. | $278.09 | -1.6% | $37.1B | 119.4 | 301.4% | — | Healthcare | -11% | 82.6% | ||
| 5 | Revolution Medicines, Inc. | $162.99 | 3.3% | $34.65B | -27.4 | -77.3% | — | Healthcare | 308.2% | — | ||
| 6 | Spyre Therapeutics, Inc. | $88.34 | 1% | $30.57B | -44.6 | 12.4% | — | Healthcare | 485.8% | — | ||
| 7 | Moderna, Inc. | $63.96 | 3.5% | $25.37B | -8.8 | 6.6% | — | Healthcare | 151.8% | -29.1% | ||
| 8 | BioNTech SE | $90.89 | -1.4% | $22.98B | -17.6 | -64.8% | — | Healthcare | -12.9% | 4% | ||
| 9 | United Therapeutics Corporation | $536.59 | -2.7% | $22.78B | 19.3 | 7.9% | — | Healthcare | 83.9% | 5.9% | ||
| 10 | Royalty Pharma plc | $52.96 | -1.4% | $22.69B | 29.4 | -23.7% | 1.3% | Healthcare | 51.7% | 7.8% | ||
| 11 | Roivant Sciences Ltd. | $31.43 | 0.7% | $22.61B | -73.1 | 25% | — | Healthcare | 174.7% | -67.7% | ||
| 12 | Incyte Corporation | $98.22 | -0.8% | $19.62B | 15.3 | 2112.5% | — | Healthcare | 43.9% | 21.5% | ||
| 13 | Genmab A/S | $25.27 | -0.5% | $15.51B | 16.4 | -59.7% | — | Healthcare | 17.2% | -34.4% | ||
| 14 | Ascendis Pharma A/S | $230.83 | -0.1% | $14.26B | -55.7 | 229.7% | — | Healthcare | 35.2% | 135.3% | ||
| 15 | Jazz Pharmaceuticals plc | $224.66 | -1% | $14.09B | -38.5 | -98.5% | — | Healthcare | 107.6% | 9.2% | ||
| 16 | Exelixis, Inc. | $51.91 | -1% | $13.19B | 18.7 | 37.9% | — | Healthcare | 27.4% | 3.3% | ||
| 17 | BridgeBio Pharma, Inc. | $66.27 | -1.7% | $12.98B | -17.5 | -6.2% | — | Healthcare | 65.7% | 355.2% | ||
| 18 | Axsome Therapeutics, Inc. | $250.50 | -0.7% | $12.89B | -68.1 | 35.4% | — | Healthcare | 143.5% | 63.9% | ||
| 19 | Ionis Pharmaceuticals, Inc. | $74.12 | -0.3% | $12.25B | -31.1 | 30.1% | — | Healthcare | 100.3% | 47.5% | ||
| 20 | Madrigal Pharmaceuticals, Inc. | $505.75 | 1.2% | $11.66B | -39.4 | 29.1% | — | Healthcare | 78.9% | 256.8% | ||
| 21 | Arrowhead Pharmaceuticals, Inc. | $81.82 | 1% | $11.52B | -6706.6 | -50.7% | — | Healthcare | 423.8% | 14.1% | ||
| 22 | Summit Therapeutics Inc. | $13.75 | -2.3% | $10.66B | -9.5 | -414.1% | — | Healthcare | -31.8% | — | ||
| 23 | BioMarin Pharmaceutical Inc. | $54.69 | -0.6% | $10.52B | 30.4 | -48.3% | — | Healthcare | -1% | 9.9% | ||
| 24 | Krystal Biotech, Inc. | $348.06 | 1.9% | $10.26B | 50.9 | 79.8% | — | Healthcare | 163.5% | 25.1% | ||
| 25 | Cytokinetics, Incorporated | $78.78 | 0.9% | $9.7B | -12.0 | -29.1% | — | Healthcare | 140.7% | 450.6% | ||
| 26 | Nuvalent, Inc. | $123.43 | 0.1% | $9.08B | -21.1 | -38% | — | Healthcare | 63.4% | — | ||
| 27 | Bio-Techne Corporation | $57.94 | 5.3% | $9.07B | 126.0 | -15.9% | 0.5% | Healthcare | 15.6% | 0.2% | ||
| 28 | Corcept Therapeutics Incorporated | $79.91 | -2.3% | $8.58B | 97.5 | -69.8% | — | Healthcare | 12.2% | 12.2% | ||
| 29 | Praxis Precision Medicines, Inc. | $282.31 | 4.6% | $8.15B | -20.9 | -24.7% | — | Healthcare | 557% | -100% | ||
| 30 | TG Therapeutics, Inc. | $53.22 | 3.3% | $8.15B | 19.2 | 1070.7% | — | Healthcare | 51.3% | 81.3% | ||
| 31 | Halozyme Therapeutics, Inc. | $68.55 | -0% | $8.13B | 26.8 | -26.1% | — | Healthcare | 29% | 39.1% | ||
| 32 | ImmunityBio, Inc. | $7.36 | 5.3% | $7.71B | -19.4 | -52.4% | — | Healthcare | 159.2% | 351.5% | ||
| 33 | Alkermes plc | $44.99 | 1.1% | $7.5B | 31.5 | -56.9% | — | Healthcare | 53.4% | 3.2% | ||
| 34 | Metsera, Inc. | $70.50 | 0% | $7.43B | -34.7 | — | — | Healthcare | 154.4% | — | ||
| 35 | Vaxcyte, Inc. | $51.44 | 1.5% | $7.43B | -9.1 | -68.5% | — | Healthcare | 54% | — | ||
| 36 | Kymera Therapeutics, Inc. | $90.43 | 0.6% | $7.38B | -24.5 | -15.5% | — | Healthcare | 94.7% | -12.6% | ||
| 37 | Protagonist Therapeutics, Inc. | $112.86 | 1.3% | $7.26B | -55.1 | -341.3% | — | Healthcare | 109.3% | -91.5% | ||
| 38 | Immunovant, Inc. | $35.34 | 1.8% | $7.26B | -12.8 | -1.5% | — | Healthcare | 122.8% | — | ||
| 39 | Cidara Therapeutics, Inc. | $221.38 | 0% | $6.96B | -8.3 | 53.8% | — | Healthcare | 938.9% | -100% | ||
| 40 | Merus N.V. | $90.00 | 0% | $6.83B | -26.9 | -36.9% | — | Healthcare | 71.1% | 55.9% | ||
Showing 40 of 647 stocks